$Tiger Brokers(TIGR)$ The more Tiger dips the more attractive it gets haven’t bought in yet but I’m almost there! 🍿🚨 Support and Resistance Flip here on our retest! Expect a bounce off of this area immediately next week! Their most recent quarter showed strong trends and these appear to be continuing. China has bottomed out for now it seems, It can easily go $15+ within a month

$Advanced Micro Devices(AMD)$ AMD is the only company nipping at the heels of $NVIDIA Corp(NVDA)$ , with the ability to go much further, including eclipsing Nvidia, and yet it's in the dumpster. Buying now is how money is earned later. AMD will, once again, show rapid AI related sales escalation during the upcoming ER. Reminds me of the battle between AMD and $Intel(INTC)$ , except it's in overdrive. At some point, enough investors will clue in, and AMD will leave the $100 - $200 range behind for good.

$NVIDIA Corp(NVDA)$ NVDA is doing exactly what you would expect. The most popular stock, pumps so much it splits, climbs for a bit after the split &comes back down to retest the split price. I would expect it to dip below the price before recovering, but it's holding for now. We'll see how it goes.

The year-to-date stock price performance of SNOW$Snowflake(SNOW)$ and PLTR$Palantir Technologies Inc.(PLTR)$ have been poor on both an absolute and relative basis. Snowflake's And Palantir's 2022 Year-To-Date Share Price Performance The shares of Palantir and Snowflake were down by -29.5% and -37.4%, respectively, so far this year. During the same period, the S&P 500 declined by a relatively modest -5.2%. Both SNOW and PLTR saw their shares fall the most around mid-March 2022. A March 11, 2022 article highlighted that "Snowflake shares fell sharply" on the day alongside "several other cloud-related stocks, as investors continued to shun technology stocks."Apart from weak investor sentiment, which has h

Avid stock market watchers will know the biotech space operates according to a different rule set. One session can wipe off a huge chunk of a stock’s valuation, if clinical testing goes awry or the regulators pick holes in a drug’s development. Yet, the opposite also holds true; shares can deliver unseemly gains if the news flow is decidedly positive. Fortunately for Veru$Veru Inc.(VERU)$ investors, this week saw plenty of the latter. Shares soared by 182% in one session, after the company announced positive data from a phase 3 clinical trial of its Covid-19 treatment, sabizabulin. In fact, the data was so good, that the company announced it was halting the late-stage testing. An interim analysis of hospitalized patients with moderate to severe COVID

$Arm Holdings(ARM)$ $Alphabet(GOOG)$ $Qualcomm(QCOM)$ QCOM and GOOG collaborating on a #RISC-V wearable chipset and OS poses a noteworthy challenge to ARM. The legal disputes involving Arm, Qualcomm, and Nuvia may have expedited this move. Given the advancing wearables market, it could potentially impede Arm's future expansion.

Thesis Rivian Automotive, Inc. $Rivian Automotive, Inc.(RIVN)$ is facing the same problem encountered by other EV start-ups, difficulty in scaling production because of supply shortages. And while the company may not be responsible for the problem, it continues adding production capacity while barely utilizing half of its already existing manufacturing facility. This is resulting in spiraling operating expenses at a time when Ford $Ford(F)$ is entering the EV truck and SUV space in full force. Rivian’s inability to ramp production will continue to hurt stock price performance. Slow Ramp and Growing Overhead Rivian is an EV maker that specializes in electric pick-up trucks and SUVs. The company currently has one op

$DBS Group Holdings(D05.SI)$ At S$38.99, I still think DBS Group is a buy. The stock has delivered nearly 100% capital gains and around S$6 in dividends since 2020—talk about a strong track record! Over 125% returns are impressive, turning every S$10,000 into more than S$22,500. That's the kind of performance that catches my eye. With its solid history, DBS seems well-positioned for future growth, making it a great addition to any portfolio.